Corporate News

George Clinical Celebrates our Global Team Members on Clinical Trials Day

The important achievements of clinical research around the world hold the potential to improve the health and wellness of humanity. Both leading projects day to day as well going the extra mile behind the scenes stand more than 300 of our dedicated, professional project team members across 38 geographical locations throughout the USA, Asia-Pacific region and […]

Read More

May 21st, 2021

DARE-19 Phase III Collaboration between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile Was Consistent in Patients with COVID-19

Detailed results from the primary analysis of the DARE-19 Phase III trial assessing the potential of Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, to treat patients hospitalized with COVID-19 who are at risk of developing serious complications showed that the trial did not achieve statistical significance for the two primary endpoints. However, there were […]

Read More

May 19th, 2021

Link Health and George Clinical Create New Mode of Pharmaceutical Research and Development in China

BEIJING and SYDNEY, April 29, 2021 – Guangzhou Link Health Pharma Co., Ltd. (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co., Ltd (Link-George). Link-George will deliver clinical trials for […]

Read More

April 30th, 2021
Adrian Liew

Scientific Leader Adrian Liew Wins the ISPD John Maher Award

Dr. Adrian Liew, a nephrologist and scientific leader with George Clinical, was the recipient of the 2020 International Society for Peritoneal Dialysis Congress John Maher Award, honoring young individuals who have contributed substantially to the field of peritoneal dialysis (PD).  Maher was a great contributor to the advancement of hemodialysis and peritoneal dialysis. He directed […]

Read More

April 2nd, 2021

Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., February 23, 2021 – David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based in Australia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.  Professor Hunter’s research focus is clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of […]

Read More

February 22nd, 2021

A Message from Our CEO Regarding COVID-19

The COVID-19 pandemic continues to bring challenges to all of us on personal and professional levels but the importance of clinical research has perhaps never been higher. Our priority at George Clinical continues to be the safety and wellbeing of our employees, patients, investigators, clients and partners as we continue to execute critical studies in […]

Read More

February 21st, 2021

Stories from George Clinical Team Conducting a Major COVID-19 Trial at the Height of Worldwide Lockdowns

“Extraordinary achievements under unprecedented conditions,” is how Chief Medical Officer Maria Ali describes the reality of a George Clinical team drawing on proven working models, established global relationships and an unflinching dedication to implement a clinical trial in a matter of weeks during a global pandemic.   Getting the job done despite extreme conditions The […]

Read More

January 21st, 2021

Oncologist Herbert Loong Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., January 15, 2021 – Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.  Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical […]

Read More

January 15th, 2021

Race Oncology Breast Cancer Clinical Trial Initiated with George Clinical

Race Oncology announced recently that it has appointed George Clinical to scope and cost a proof-of-concept Phase I/II breast cancer clinical trial of Bisantrene in combination with cyclophosphamide. This program will enable the Race Oncology Board to make a fully informed and costed decision on this important clinical pathway before expending significant shareholder funds. Bisantrene […]

Read More

December 12th, 2020

George Clinical Attends DIA China

George Clinical team members recently participated in the 12th Annual DIA China Meeting, the largest Chinese event in the life sciences industry. The conference is designed to “foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies in the APAC region.” Around 3,000 pharmaceutical R&D professionals […]

Read More

November 13th, 2020

Add George Clinical to your network